Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 1,730,655 | 806,780 | 937,822 | 698,801 | 538,593 |
| Cost of Goods | 47,013 | 57,398 | 65,486 | 44,678 | 32,328 |
| Gross Profit | 1,683,642 | 749,382 | 872,336 | 654,123 | 506,265 |
| Operating Expenses | 816,720 | 1,052,350 | 1,312,324 | 1,102,210 | 881,036 |
| Operating Income | 866,935 | -302,570 | -439,502 | -447,409 | -374,443 |
| Interest Expense | 152,230 | 166,993 | 129,180 | 90,871 | 86,022 |
| Other Income | -18,086 | 106,444 | -127,428 | -49,207 | -57,875 |
| Pre-tax Income | 696,619 | -363,119 | -696,110 | -587,487 | -518,340 |
| Income Tax | 13,975 | 176 | -69,506 | -28,470 | 5,561 |
| Net Income Continuous | 682,644 | -363,295 | -626,604 | -559,017 | -523,901 |
| Net Income | $682,644 | $-363,295 | $-626,604 | $-559,017 | $-523,901 |
| EPS Basic Total Ops | 8.58 | -4.73 | -8.37 | -7.79 | -7.43 |
| EPS Basic Continuous Ops | 8.58 | -4.73 | -8.37 | -7.79 | -7.43 |
| EPS Diluted Total Ops | 7.78 | -4.73 | -8.37 | -7.79 | -7.43 |
| EPS Diluted Continuous Ops | 7.73 | -4.73 | -8.37 | -7.79 | -7.43 |
| EPS Diluted Before Non-Recurring Items | 7.78 | -4.12 | -3.62 | -7.79 | -7.43 |
| EBITDA(a) | $888,947 | $-78,690 | $14,561 | $-281,575 | $-303,162 |